Tags specialty pharmacy specialty pharmacy Pharmacies that dispense complex and costly drugs, often by mail, with patient support.
Industry · 3 companies · 1 report it as a revenue line
Sells it, part of Patient And Digital Solutions“We also offer specialized pharmacy services for transplant patients.”
Latest 10-K FY2025 Mixed · Filed Feb 25
Pharmacy and Ottr expansion drive growth beyond testing, while reimbursement and collection adjustments limit revenue per test.
Revenue $379.8M YoY +13.8% Net income −$21.4M vs $52.5M year ago Latest 10-Q Q3 FY2026 Positive · Filed Oct 29
Naveris adds NavDx oncology testing as lab products exit; accelerating transplant demand and older-test revenue recognition fuel growth.
Revenue $139.4M YoY +39.3% Net income $19.3M vs $1.7M year ago Latest 8-K Positive Earnings Guidance raised · Filed Oct 29
Testing Services growth, including NavDx oncology, fuels higher FY2026 revenue guidance of $520M–$530M.
Latest 8-K Positive Deal completed · Filed Jul 7
Sold Lab Products to Eurobio for $171.7M and acquired Naveris for $161.8M upfront, adding NavDx specialty oncology testing.
Latest 8-K Executive pay Shareholder vote · Filed Jun 15
Stockholders approved adding 1.6M shares to the 2024 Equity Incentive Plan reserve.
Sells it 28%, $20.5B a quarter“Q3 pharmacy revenue growth was led by network revenue, up to $34.909 billion from $32.525 billion; home-delivery and specialty revenue was nearly flat at $20.485 billion versus $20.513 billion.”
Latest 10-Q Q3 FY2026 Mixed Restructuring · Filed Nov 5
Rebate-free investment and contract renewals squeeze Evernorth’s pharmacy-benefit earnings; specialty care provides an offset.
Revenue $73.7B YoY +5.6% Net income $1.4B YoY −22.8% Latest 8-K Earnings Guidance raised · Filed Nov 5
Pharmacy Benefit Services renewals and investments squeezed income; FY2026 adjusted EPS outlook raised to at least $30.60
Latest 8-K Leadership change · Filed Oct 9
Donna F. Zarcone will retire from Cigna’s board effective Dec. 31, 2026.
Latest 8-K Positive Earnings Guidance raised Restructuring · Filed Jul 30
U.S. Employer margin gains lifted Cigna Healthcare income; client initiatives and contract renewals weighed on pharmacy benefit income.
Sells it“Pharmacy network revenue was $28.258 billion from $26.408 billion, and mail and specialty revenue was $23.153 billion from $20.392 billion.”
Latest 10-Q Q3 FY2026 Mixed · Filed Nov 4
Planned split separates Aetna and Caremark from CVS Pharmacy as insurance profitability improves and pharmacy pricing pressure persists.
Revenue $108.4B YoY +5.4% Net income $2.2B vs −$4.0B year ago Latest 8-K Positive Guidance raised Deal pending Earnings · Filed Nov 4
Planned split of Aetna and CVS Caremark from CVS Pharmacy targets more focused strategies and capital allocation
Latest 8-K Leadership change · Filed Aug 17
Larry Robbins resigns from the Board; JPMorgan Chase data & analytics chief Teresa Heitsenrether appointed as an independent director
No companies have a recent 8-K matching these events. Show all 8-K events
No companies in the selected roles.